Consistent with these findings, we further observed that plasma CCL2 levels were significantly higher within the Cancer TIF1-γ-DM group than in the Non-cancer TIF1-γ-DM and HC groups (Figures 2 and 3). Here, TRIM33 is linked to cancer.